Zynerba Pharmaceuticals, Inc. (ZYNE) - Quarterly Income Statement

Home
ZYNE
Financials

1.3 (USD) • At close October 10, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1
Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.086	0	0	0	0	0	0	0	0	0	0	0.007	0.049	0.199	0.015	0.015	0.074	0.525	0.064	0.146
Cost of Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.086	0	0	0	0	0	0	0	0	0	0	0.007	0.049	0.199	0.015	0.015	0.074	0.525	0.064	0.146
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1
Reseach & Development Expenses Numbers are in millions	7.167	7.078	5.468	5.039	5.446	5.147	5.022	6.341	5.452	4.609	5.616	5.806	17.35	6.883	7.458	-1.604	8.224	6.307	4.876	4.86	8.533	8.976	5.828	5.754	5.733	5.491	4.904	4.504	4.807	2.569	3.309	2.272	1.011	0.854	0.816	0.933	0.367	0.286
General & Administrative Expenses Numbers are in millions	3.969	3.393	3.218	3.454	3.722	3.757	3.814	3.869	4.387	3.276	4.573	3.426	4.492	3.917	3.958	3.531	3.287	3.16	3.256	3.126	3.436	3.421	2.376	2.796	2.633	2.212	1.78	1.493	1.476	1.68	2.156	1.923	0.631	0.654	0.663	2.108	1.206	0.1
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	3.969	3.393	3.218	3.454	3.722	3.757	3.814	3.869	4.387	3.276	4.573	3.426	4.492	3.917	3.958	3.531	3.287	3.16	3.256	3.126	3.436	3.421	2.376	2.796	2.633	2.212	1.78	1.493	1.476	1.68	2.156	1.923	0.631	0.654	0.663	2.108	1.206	0.1
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	11.136	10.471	8.686	8.493	9.169	8.904	8.836	10.211	9.838	7.885	10.19	9.232	21.842	10.799	11.416	1.926	11.511	9.466	8.132	7.986	11.97	12.396	8.205	8.55	8.366	7.703	6.685	5.998	6.284	4.249	5.465	4.195	1.642	1.507	1.478	3.04	1.573	0.385
Operating Income Numbers are in millions	-11.136	-10.471	-8.686	-8.493	-9.169	-8.904	-8.836	-10.211	-9.838	-7.885	-10.19	-9.232	-21.842	-10.799	-11.416	-1.926	-11.511	-9.466	-8.046	-7.986	-11.97	-12.396	-8.205	-8.55	-8.366	-7.703	-6.685	-5.998	-6.284	-4.242	-5.416	-3.995	-1.627	-1.493	-1.404	-2.515	-1.509	-0.239
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-93.561	0	0	0	0	0	0	0	0	0	0	-585.085	-109.916	-20.036	-105.723	-100.664	-18.937	-4.786	-23.548	-1.635
Total Other Income Expenses Net Numbers are in millions	-0.075	0.357	0.67	-0.183	-0.684	0.317	0.017	-0.377	-0.118	-0.082	0.567	0.172	1.483	-1.74	0.406	-0.457	-0.063	-0.032	-0.066	-0.1	-0.224	-0.085	-0.07	0.076	-0.082	0.367	-0.239	-0.006	-0.02	-0.023	0.004	0.002	0.001	0.001	0	-0	-0	-0.001
Income Before Tax Numbers are in millions	-10.776	-10.114	-8.016	-8.676	-9.853	-8.491	-8.815	-10.582	-9.95	-7.962	-9.618	-9.049	-20.333	-12.338	-10.715	-1.946	-11.135	-9.147	-7.79	-7.807	-12.007	-12.306	-8.119	-8.311	-8.323	-7.259	-6.897	-5.981	-6.286	-4.253	-5.412	-3.994	-1.626	-1.492	-1.404	-2.515	-1.51	-0.24
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-90.584	0	0	0	0	0	0	0	0	0	0	-586.571	-109.827	-20.028	-105.677	-100.618	-18.937	-4.787	-23.553	-1.643
Income Tax Expense Numbers are in millions	-0.36	-0.357	-0.399	0.183	0.684	-0.413	-0.083	0.372	0.112	0.077	-0.632	-0.183	-1.509	1.538	-0.737	0.02	-0.376	-0.319	-0.282	-0.178	0.037	-0.09	-0.112	-0.238	-0.042	-0.444	0.19	-0.016	-0.056	0.029	0.028	0	0	0	0	0	0	0
Net Income Numbers are in millions	-10.776	-9.757	-7.617	-8.859	-10.537	-8.491	-8.815	-10.582	-9.95	-7.962	-9.618	-9.049	-20.333	-12.338	-10.715	-1.946	-11.135	-9.147	-7.79	-7.807	-12.007	-12.306	-8.119	-8.311	-8.323	-7.259	-6.897	-5.981	-6.229	-4.281	-5.439	-3.994	-1.626	-1.492	-1.404	-2.515	-1.51	-0.24
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-90.584	0	0	0	0	0	0	0	0	0	0	-590.534	-110.386	-20.028	-105.677	-100.618	-18.937	-4.787	-23.553	-1.643
EPS Numbers are in millions	-0.21	-0.2	-0.17	-0.2	-0.25	-0.21	-0.22	-0.26	-0.25	-0.2	-0.33	-0.31	-0.78	-0.53	-0.46	-0.084	-0.5	-0.47	-0.44	-0.47	-0.89	-0.91	-0.6	-0.63	-0.64	-0.6	-0.71	-0.67	-0.7	-0.49	-0.59	-0.66	-0.19	-0.26	-0.24	-0.44	-0.26	-0.042
EPS Diluted Numbers are in millions	-0.21	-0.2	-0.17	-0.2	-0.25	-0.21	-0.22	-0.26	-0.25	-0.2	-0.33	-0.31	-0.78	-0.53	-0.46	-0.084	-0.5	-0.47	-0.44	-0.47	-0.89	-0.91	-0.6	-0.63	-0.64	-0.6	-0.71	-0.67	-0.7	-0.49	-0.59	-0.66	-0.19	-0.26	-0.24	-0.44	-0.26	-0.042
EBITDA Numbers are in millions	-10.996	-10.33	-8.949	-8.007	-8.339	-9.16	-8.853	-9.772	-9.659	-7.741	-10.756	-9.346	-23.276	-9.018	-11.822	-1.433	-11.415	-9.406	-7.981	-7.861	-11.724	-12.284	-8.134	-8.601	-8.26	-8.05	-6.446	-5.965	-6.249	-4.205	-5.403	-3.987	-1.624	-1.491	-1.403	-2.508	-1.5	-0.23
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-92.797	0	0	0	0	0	0	0	0	0	0	-580.022	-109.647	-19.995	-105.522	-100.567	-18.918	-4.773	-23.406	-1.569

Zynerba Pharmaceuticals, Inc.

NASDAQ:ZYNE Add to watchlist

NASDAQ:ZYNE